Searched for
WOCKHARDT VACCINES
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Wockhardt shareholders reject proposal to raise Rs 1,600 crore from promotorIiAS said the proposed related party transaction with KHIPL was intended for borrowing of funds for an amount up to Rs 1,600 crore for a pe...
- Wockhardt looks to roll out 2 vaccines from UK plant in 12 months as part of tie-up with Serum"Serum has identified two vaccines and we plan to manufacture these products within the next 12 months after exhibit batches and regulatory...
- Wockhardt shuts US manufacturing plantThe company expects the US plant shutdown and transfer of products from inhouse to third-party contract manufacturers to help save $12 mill...
- Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UKThe collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities al...
- Wockhardt, Serum enter pact to do fill-finish of vaccinesWockhardt UK has manufactured a COVID-19 vaccine in collaboration with UK Government and AstraZeneca. Its collaboration with Serum Life Sci...
- Local drug companies in a fix over Sputnik amid sanctions against RDIFRDIF is commercialising the Sputnik vaccine globally, which was developed by Russia's Gamaleya Research Institute.
- Wockhardt gets CDSCO approval to export Russian COVID vaccine SputnikThe approval is for the export of up to 8 crore doses of Sputnik Light and up to 2 crore doses of Sputnik V Component I vaccines, Wockhardt...
- UK PM Boris Johnson hails India's Wockhardt as vaccine rollout success storyDuring a flagship speech at the Global Investment Summit at London's Science Museum, Johnson said Wockhardt's Wales-based bottling plant wa...
- Covid-19: Wockhardt inks pact with RDIF to produce, supply Sputnik vaccineThe Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF...
- Wockhardt's COVID-19 vaccines supply deal with UK Govt extended for 6 monthsOn the development, UK International Trade Secretary Liz Truss said, "It brings important investment to the local area, bringing jobs and s...
- UK plant producing AstraZeneca vaccines partially evacuated over suspect packageWockhardt UK provides fill-and-finish capacity for AstraZeneca's UK supply chain, which is the final manufacturing step of putting vaccines...
- View: Covid vaccine development is Indian pharma's shot at global fameThe experience with Covid vaccine development has provided India a unique opportunity to burnish its credentials as a global leader in the ...
- Wockhardt in talks with a number of vaccine manufacturersManufacturing of vaccines is a big opportunity for Indian pharmaceutical industry, says Habil Khorakiwala. Wockhardt is in partmership with...
- COVID-19: Wockhardt in discussions with vaccine developers to offer drug substanceAccording to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 m...
- Wockhardt surges 10% on signing Covid-19 deal with UK governmentAs per the terms of the agreement, Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK gov...
- Wockhardt snags Covid-19 vaccine manufacturing deal from the UK govtThis deal by Wockhardt entails only manufacturing the vaccine only for the United Kingdom. The government has reserved one fill and finish ...
- Dr Reddy's completes the acquisition of Wockhardt's select generics, plantG V Prasad, Co-Chairman and Managing Director of Dr. Reddys said this deal is in line with the companys strategic focus on India and has pa...
- Wockhardt shareholders approve raising of up to Rs 1,000 croreShares of Wockhardt were trading at Rs 636.30 per scrip in the afternoon trade on the BSE.
- Pfizer, Sanofi vie for Wockhardt biotechWockhardt may have to hive off its biotech business into a separate company to clear the way for another company to pick up stake.
Load More
